CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 408 enrolled
Drug / intervention
Proctofoam-HC®drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00405288
NCT00405288N/ACompleted
CompareCT.gov

The Safety of Proctofoam-HC in the Third Trimester of Pregnancy

The Hospital for Sick Children·observational·Posted Nov 30, 2006·Updated Feb 5, 2014

In Brief

An observational study evaluating Proctofoam-HC® for Hemorrhoids and Pregnancy. Completed, enrolled 408 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the fetal safety of topical application of Proctofoam-HC®, an antihemorrhoidal, in the third trimester of pregnancy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhoids, Pregnancy
CountriesCanada
CollaboratorsDuchesnay Inc.

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 30, 2006
Enrollment StartNov 1, 2006
Primary CompletionNov 1, 2009
Study CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 19.6 years ago

Interventions

Proctofoam-HC®drug

Observational study of the exposure to Proctofoam-HC®